UnitedHealth Group Incorporated $UNH Shares Sold by Price T Rowe Associates Inc. MD

Key Points

• Price T Rowe Associates Inc. MD reduced its stake in UnitedHealth Group by 0.0% in Q1, maintaining its position as the 10th largest holding within the fund's portfolio.
• UnitedHealth Group recently declared a quarterly dividend of $2.21 per share, resulting in an annualized dividend yield of 2.9% and a payout ratio of 38.30%.
• JPMorgan Chase & Co. has decreased their price target on UnitedHealth Group from $418.00 to $310.00, while the company has a consensus rating of "Moderate Buy" among analysts.

Price T Rowe Associates Inc. MD lessened its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 0.0% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 21,393,161 shares of the healthcare conglomerate's stock after selling 8,593 shares during the quarter. UnitedHealth Group comprises approximately 1.4% of Price T Rowe Associates Inc. MD's investment portfolio, making the stock its 10th largest holding. Price T Rowe Associates Inc. MD owned 2.36% of UnitedHealth Group worth $11,204,669,000 at the end of the most recent quarter.

Several other hedge funds have also bought and sold shares of UNH. GAMMA Investing LLC boosted its position in UnitedHealth Group by 56,142.1% in the 1st quarter. GAMMA Investing LLC now owns 8,295,153 shares of the healthcare conglomerate's stock worth $4,344,586,000 after purchasing an additional 8,280,404 shares in the last quarter. Nuveen LLC purchased a new stake in UnitedHealth Group in the 1st quarter worth approximately $3,846,764,000. Vanguard Group Inc. boosted its position in UnitedHealth Group by 6.6% in the 1st quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate's stock worth $47,519,620,000 after purchasing an additional 5,583,343 shares in the last quarter. Wellington Management Group LLP boosted its position in UnitedHealth Group by 10.6% in the 1st quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate's stock worth $13,537,859,000 after purchasing an additional 2,486,839 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in shares of UnitedHealth Group by 36.6% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 8,592,718 shares of the healthcare conglomerate's stock valued at $4,346,712,000 after buying an additional 2,301,010 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company's stock.

UnitedHealth Group Trading Up 1.2%

Shares of UNH traded up $3.7480 during midday trading on Friday, reaching $307.0980. The company had a trading volume of 14,867,565 shares, compared to its average volume of 23,516,492. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $630.73. The stock has a market cap of $278.13 billion, a PE ratio of 13.31, a price-to-earnings-growth ratio of 1.96 and a beta of 0.43. The firm has a 50 day simple moving average of $288.39 and a 200-day simple moving average of $389.57. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The company had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. During the same period last year, the business earned $6.80 earnings per share. The firm's revenue was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 23rd. Investors of record on Monday, September 15th will be given a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.9%. The ex-dividend date of this dividend is Monday, September 15th. UnitedHealth Group's dividend payout ratio (DPR) is presently 38.30%.

Analysts Set New Price Targets

A number of research analysts have recently issued reports on UNH shares. KeyCorp decreased their target price on UnitedHealth Group from $400.00 to $350.00 and set an "overweight" rating on the stock in a research report on Wednesday, July 30th. Bank of America increased their target price on UnitedHealth Group from $290.00 to $325.00 and gave the company a "neutral" rating in a research report on Monday. Royal Bank Of Canada decreased their target price on UnitedHealth Group from $355.00 to $286.00 and set an "outperform" rating on the stock in a research report on Wednesday, July 30th. Wall Street Zen lowered UnitedHealth Group from a "buy" rating to a "hold" rating in a research report on Saturday, May 24th. Finally, Wells Fargo & Company decreased their price objective on UnitedHealth Group from $306.00 to $267.00 and set an "overweight" rating on the stock in a report on Monday, August 4th. Fifteen investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have given a Sell rating to the company. According to MarketBeat, UnitedHealth Group has an average rating of "Moderate Buy" and an average target price of $365.38.

Insider Activity

In related news, CEO Patrick Hugh Conway sold 589 shares of the firm's stock in a transaction dated Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total transaction of $179,645.00. Following the completion of the sale, the chief executive officer directly owned 10,398 shares of the company's stock, valued at approximately $3,171,390. This trade represents a 5.36% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 0.28% of the company's stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.